CCM
AVEO

Chicago Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Chicago Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,000
Closed -$374K – 33
2022
Q4 		$374K Buy
+25,000
New +$346K 0.34% 24

Chicago Capital Management's AVEO Position: Q1 2023 in Review

Chicago Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 25,000 shares — an estimated $374K sold.

Chicago Capital Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $374K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Chicago Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Chicago Capital Management sold 25,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $374K.
  • Chicago Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Chicago Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $374K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Chicago Capital Management's 13F filing for Q1 2023, filed 11 May 2023.